Indefinite Delivery Contract SPE2DX15D2104

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of a comprehensive range of pharmaceutical products and medical supplies. The single-award IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver essential medications, vaccines, devices, and other critical medical commodities to support military healthcare programs globally. The contract encompasses a broad spectrum of pharmaceutical and medical supply requirements, including specialty medications, brand-name and generic drugs, syringes, vials, and diagnostic test kits across multiple therapeutic areas. The contract does not have any set-aside requirements, indicating open competition. The place of performance is Amerisourcebergen's facilities in Chesterbrook and Conshohocken, Pennsylvania. This IDC, which runs through December 2025, enables the DLA to efficiently procure necessary pharmaceutical and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism.

In addition to the overarching IDC, the contract has numerous associated delivery orders that provide specific quantities and pricing for various medical products and commodities. These delivery orders, issued under the IDC, cover a wide range of pharmaceuticals, devices, and other supplies required to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The delivery orders are awarded on a firm-fixed-price basis, with the place of performance remaining at Amerisourcebergen's facilities in Pennsylvania. The cumulative value of these delivery orders demonstrates the significant scale and diversity of medical supplies being provided to the Defense Logistics Agency through this comprehensive IDC.